MRK · News · 20260805N

Litigation and Legal Risk

Merck & Co., Inc. · 2026-08-05 · Importance 31 · Surprise 42

A shareholder class action alleges that Merck made misleading statements about projected Gardasil revenue in China. The alleged securities-fraud period runs from February 3, 2022, through February 3, 2025. The reported notice concerns potential investor claims and does not state a settlement amount, judgment, or quantified financial exposure.

Key facts

• Levi & Korsinsky notified shareholders of a class action lawsuit alleging securities fraud between February 3, 2022 and February 3, 2025 related to Merck's projected Gardasil revenue in China. source